End-of-day quote
Pakistan S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
80.85
PKR
|
-0.80%
|
|
-1.39%
|
+14.99%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
27,818
|
31,886
|
27,157
|
18,197
|
19,687
|
22,638
|
Enterprise Value (EV)
1 |
27,818
|
31,886
|
27,157
|
18,197
|
19,687
|
22,638
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
3.27%
|
1.76%
|
2.58%
|
3.08%
|
3.56%
|
4.64%
|
Capitalization / Revenue
|
4.45
x
|
4.59
x
|
2.91
x
|
1.26
x
|
1.05
x
|
1.17
x
|
EV / Revenue
|
4.45
x
|
4.59
x
|
2.91
x
|
1.26
x
|
1.05
x
|
1.17
x
|
EV / EBITDA
|
-
|
-
|
-
|
5,392,754
x
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
1.73
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
280,000
|
280,000
|
280,000
|
280,000
|
280,000
|
280,000
|
Reference price
2 |
99.35
|
113.9
|
96.99
|
64.99
|
70.31
|
80.85
|
Announcement Date
|
3/13/20
|
2/26/21
|
3/24/22
|
3/28/23
|
2/29/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
6,253
|
6,946
|
9,317
|
14,459
|
18,743
|
19,431
|
EBITDA
|
-
|
-
|
-
|
3,374
|
-
|
-
|
EBIT
|
2,052
|
2,078
|
2,513
|
3,123
|
-
|
-
|
Operating Margin
|
32.81%
|
29.92%
|
26.97%
|
21.6%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
3.250
|
2.000
|
2.500
|
2.000
|
2.500
|
3.750
|
Announcement Date
|
3/13/20
|
2/26/21
|
3/24/22
|
3/28/23
|
2/29/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
15.5%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
9.99%
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
37.70
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/13/20
|
2/26/21
|
3/24/22
|
3/28/23
|
2/29/24
|
-
|
Last Close Price
80.85
PKR Average target price
100
PKR Spread / Average Target +23.69% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.99% | 81.29M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|